This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Novartis has received approval from the U.S. Food and Drug Administration (FDA) for earlier use of Pluvicto to treat patients with advanced prostate cancer. The new indication approximately triples the eligible patient population, allowing Pluvicto to be used after one androgen receptor pathway inhibitor (ARPI) treatment and now prior to chemotherapy, Novartis said in a statement.
Renaissance Imaging Medical Associates, a California-based Rad Partners affiliate, allegedly created false radiology reports supporting the diagnosis of spinal enthesopathy.
Excess imaging translates to "significant"carbon dioxide (CO2) emissions, according to a study published March 28 in the Journal of the American College of Radiology. How significant? Up to 129 kilotons of emissions annually -- the same as would be produced from powering a town of more than 70,000 people for a year, according to a statement released by the Harvey L.
Scientists have confirmed a neurobiochemical link between dopamine and cognitive flexibility. PET imaging shows that the brain increases dopamine production when completing cognitively demanding tasks, and that the more dopamine released, the more efficiently the tasks are completed. Armed with this information, physicians may soon be able to develop more precise treatment strategies for neurological and psychiatric disorders.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
Ultromics has added a probability scoring feature to its EchoGo Heart Failure AI screening software for the detection of heart failure with preserved ejection fraction (HFpEF). The Oxford, U.K.-based firm said in a statement that it has added an AI-powered probability scoring system that generates a continuous score of the likelihood of disease to EchoGo Heart Failure.
Men should have prostate-specific membrane antigen (PSMA) PET scans about eight months after undergoing external beam radiotherapy for prostate cancer, a group at the University of California, Los Angeles has reported. The finding is from an analysis of 89 patients with 217 irradiated lesions, with scans used to determine how patients respond to the treatment, noted Masatoshi Hotta, MD, and colleagues.
Imaging industry giant Rad Partners led the way, initiating 110,000 payment disputes in the first half of 2024, the Centers for Medicare & Medicaid Services reports.
GE HealthCare (GEHC) will introduce its Revolution Vibe CT system at the American College of Cardiology (ACC) 2025 meeting to be held in Chicago March 29 to 31. Ge Healthcare's Revolution Vibe system. Image courtesy of GE Healthcare. The Revolution Vibe system, designed with GEHC's Unlimited One-Beat Cardiac technology for all heart rates and rhythms, provides full-heart, low-dose imaging for patients with conditions such as atrial fibrillation, breath-holding difficulties, heavily calcified cor
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
Some really good follows on the Imaging Wire’s 2025 list of Top 40 Radiology Resources. I’ll happily accept the description of “excellent insights into the vagaries of being a working radiologist.” The post Top 40 Radiology Resources first appeared on Ben White.
Founded in 1984, Casslings mission is to strengthen community healthcare. The company strives to bring innovative imaging solutions to communities and providers, so that patients and their families can live their best life. Thats why Cassling is excited to introduce a new awards program that recognizes and celebrates imaging teams contributions to keeping care local and improving patient outcomes.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
Cost of Botox injections may increase when medical imaging, like ultrasound, is used to guide accurate placement. The post The Cost of Botox Injections: What Factors Affect Pricing appeared first on Open MedScience.
Recent research demonstrated a 59 percent reduced risk of progression or death with the radioligand therapy Pluvicto in comparison to a change of androgen receptor pathway inhibitor (ARPI) for patients with metastatic castration-resistant prostate cancer (mCRPC).
Jumpfactor Marketing delivers expert strategies that help managed IT service providers grow, convert leads, and scale effectively. The post Mastering Expert Strategies At Jumpfactor For Marketing Success appeared first on Open MedScience.
The positron emission tomography myocardial perfusion imaging (PET MPI) agent, which offers a significantly higher half-life than other cardiac PET agents, was recently granted pass-through payment status by CMS that will go into effect on April 1, 2025.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
Artificial intelligence (AI)-powered measurement capabilities provide key features with the Compact Ultrasound 5500CV device, which will be unveiled at the American College of Cardiology (ACC) conference.
Publication date: Available online 28 March 2025 Source: Clinical Radiology Author(s): Qing-Hai Zhang, Shu-Shen Lin, Xi Zhao, Zhi Qin, Hong Ge, Jin-Xin Qian, Yuan-Cheng Wang
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content